Shao‐Chih Chiu

1.9k total citations
60 papers, 1.5k citations indexed

About

Shao‐Chih Chiu is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Shao‐Chih Chiu has authored 60 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Molecular Biology, 15 papers in Immunology and 13 papers in Oncology. Recurrent topics in Shao‐Chih Chiu's work include Immunotherapy and Immune Responses (9 papers), Immune Cell Function and Interaction (7 papers) and Ubiquitin and proteasome pathways (6 papers). Shao‐Chih Chiu is often cited by papers focused on Immunotherapy and Immune Responses (9 papers), Immune Cell Function and Interaction (7 papers) and Ubiquitin and proteasome pathways (6 papers). Shao‐Chih Chiu collaborates with scholars based in Taiwan, United States and Croatia. Shao‐Chih Chiu's co-authors include Der‐Yang Cho, Shinn‐Zong Lin, Yi Ching Chen, Cicero Lee‐Tian Chang, Yenshou Lin, Wen‐Chin Yang, Ning-Sun Yang, Horng‐Jyh Harn, Chang‐Tze Ricky Yu and Chi‐Chang Juan and has published in prestigious journals such as Nature Communications, PLoS ONE and Cancer.

In The Last Decade

Shao‐Chih Chiu

57 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shao‐Chih Chiu Taiwan 24 684 283 264 230 170 60 1.5k
Chun‐Yin Huang Taiwan 30 1.2k 1.8× 321 1.1× 463 1.8× 411 1.8× 81 0.5× 60 2.2k
Huimin Bian China 19 509 0.7× 274 1.0× 204 0.8× 112 0.5× 88 0.5× 46 1.2k
Rasmus Siersbæk Denmark 15 1.7k 2.5× 196 0.7× 272 1.0× 304 1.3× 83 0.5× 23 2.5k
Elisa Ciraolo Italy 22 884 1.3× 198 0.7× 173 0.7× 83 0.4× 168 1.0× 32 1.5k
Jianling Xie Australia 25 1.0k 1.5× 175 0.6× 164 0.6× 218 0.9× 45 0.3× 55 1.8k
Ángel Hernández‐Hernández Spain 19 682 1.0× 215 0.8× 117 0.4× 211 0.9× 193 1.1× 49 1.4k
Bai‐Cheng He China 29 1.3k 1.8× 137 0.5× 205 0.8× 323 1.4× 115 0.7× 86 2.0k
Qing‐You Kong China 25 831 1.2× 148 0.5× 308 1.2× 247 1.1× 85 0.5× 47 1.4k
Bruna Pucci Italy 19 986 1.4× 140 0.5× 461 1.7× 289 1.3× 83 0.5× 26 1.9k
Bao-Wei Wang Taiwan 25 845 1.2× 128 0.5× 150 0.6× 393 1.7× 72 0.4× 47 1.6k

Countries citing papers authored by Shao‐Chih Chiu

Since Specialization
Citations

This map shows the geographic impact of Shao‐Chih Chiu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shao‐Chih Chiu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shao‐Chih Chiu more than expected).

Fields of papers citing papers by Shao‐Chih Chiu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shao‐Chih Chiu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shao‐Chih Chiu. The network helps show where Shao‐Chih Chiu may publish in the future.

Co-authorship network of co-authors of Shao‐Chih Chiu

This figure shows the co-authorship network connecting the top 25 collaborators of Shao‐Chih Chiu. A scholar is included among the top collaborators of Shao‐Chih Chiu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shao‐Chih Chiu. Shao‐Chih Chiu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wei, Tong‐You Wade, Jiun‐Yi Hsia, Tsung-Ying Yang, et al.. (2025). Mechanistic insights into CLNS1A-mediated chemoresistance and tumor progression in non-small cell lung cancer. Cancer Letters. 626. 217783–217783.
2.
Shie, Ming‐You, Shi‐Wei Huang, Yeh Chen, et al.. (2025). Engineering HLA-G-targeted extracellular vesicles nanoplatform for enhanced cancer therapy through precise cancer drug delivery. Nature Communications. 16(1). 11308–11308. 1 indexed citations
3.
Lin, Yu‐Chuan, Mei‐Chih Chen, Shi‐Wei Huang, et al.. (2024). Targeting Dual Immune Checkpoints PD‐L1 and HLA‐G by Trispecific T Cell Engager for Treating Heterogeneous Lung Cancer. Advanced Science. 11(41). e2309697–e2309697. 11 indexed citations
4.
5.
Huang, Shi‐Wei, Chih‐Ming Pan, Yu‐Chuan Lin, et al.. (2023). BiTE‐Secreting CAR‐γδT as a Dual Targeting Strategy for the Treatment of Solid Tumors. Advanced Science. 10(17). e2206856–e2206856. 32 indexed citations
6.
Lin, Yu‐Chuan, Chun‐Hung Hua, Shi‐Wei Huang, et al.. (2023). CAR-T cells targeting HLA-G as potent therapeutic strategy for EGFR-mutated and overexpressed oral cancer. iScience. 26(3). 106089–106089. 6 indexed citations
7.
Chiu, Shao‐Chih, et al.. (2023). The crescent-like Golgi ribbon is shaped by the Ajuba/PRMT5/Aurora-A complex-modified HURP. Cell Communication and Signaling. 21(1). 156–156. 1 indexed citations
8.
9.
Chiang, En‐Pei Isabel, Raymond L. Rodriguez, Wei‐Jan Wang, et al.. (2022). N-3 polyunsaturated fatty acids block the trimethylamine-N-oxide- ACE2- TMPRSS2 cascade to inhibit the infection of human endothelial progenitor cells by SARS-CoV-2. The Journal of Nutritional Biochemistry. 109. 109102–109102. 9 indexed citations
10.
Lee, Der‐Yen, et al.. (2021). Evaluations and Mechanistic Interrogation of Natural Products Isolated From Paeonia suffruticosa for the Treatment of Inflammatory Bowel Disease. Frontiers in Pharmacology. 12. 696158–696158. 3 indexed citations
11.
Pan, Chih‐Ming, Chao‐Hsuan Chen, Chia-Ing Jan, et al.. (2020). MicroRNA-7 targets T-Box 2 to inhibit epithelial-mesenchymal transition and invasiveness in glioblastoma multiforme. Cancer Letters. 493. 133–142. 17 indexed citations
12.
Chiu, Shao‐Chih, Der‐Yang Cho, Liang-Ming Lee, et al.. (2020). Cytokine-induced Killer T Cells Enhance the Cytotoxicity Against Carboplatin-resistant Ovarian Cancer Cells. Anticancer Research. 40(7). 3865–3872. 1 indexed citations
13.
Chiu, Shao‐Chih, Der‐Yang Cho, Liang‐Ming Lee, et al.. (2020). Gamma/Delta T-Cells Enhance Carboplatin-induced Cytotoxicity Towards Advanced Bladder Cancer Cells. Anticancer Research. 40(9). 5221–5227. 7 indexed citations
14.
Jan, Chia-Ing, et al.. (2018). Predictors of Response to Autologous Dendritic Cell Therapy in Glioblastoma Multiforme. Frontiers in Immunology. 9. 727–727. 61 indexed citations
15.
Chiu, Shao‐Chih, et al.. (2017). N-3 polyunsaturated fatty acids alleviate high glucose-mediated dysfunction of endothelial progenitor cells and prevent ischemic injuries both in vitro and in vivo. The Journal of Nutritional Biochemistry. 42. 172–181. 26 indexed citations
16.
Chiu, Shao‐Chih, En‐Pei Isabel Chiang, Man‐Hui Pai, et al.. (2014). Eicosapentaenoic acid induces neovasculogenesis in human endothelial progenitor cells by modulating c-kit protein and PI3-K/Akt/eNOS signaling pathways. The Journal of Nutritional Biochemistry. 25(9). 934–945. 27 indexed citations
17.
Chiang, En‐Pei Isabel, Shao‐Chih Chiu, Man‐Hui Pai, et al.. (2013). Organosulfur Garlic Compounds Induce Neovasculogenesis in Human Endothelial Progenitor Cells through a Modulation of MicroRNA 221 and the PI3-K/Akt Signaling Pathways. Journal of Agricultural and Food Chemistry. 61(20). 4839–4849. 39 indexed citations
18.
Lin, Po‐Cheng, Yilin Chen, Shao‐Chih Chiu, et al.. (2008). Orphan nuclear receptor, Nurr‐77 was a possible target gene of butylidenephthalide chemotherapy on glioblastoma multiform brain tumor. Journal of Neurochemistry. 106(3). 1017–1026. 63 indexed citations
19.
Hsieh, Huan‐Fa, Horng‐Jyh Harn, Shao‐Chih Chiu, et al.. (2000). Telomerase activity correlates with cell cycle regulators in human hepatocellular carcinoma. Liver International. 20(2). 143–151. 13 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Chun‐Yin Huang Breakdown of academic impact, for papers by Huimin Bian Breakdown of academic impact, for papers by Rasmus Siersbæk Breakdown of academic impact, for papers by Elisa Ciraolo Breakdown of academic impact, for papers by Jianling Xie Breakdown of academic impact, for papers by Ángel Hernández‐Hernández Breakdown of academic impact, for papers by Bai‐Cheng He Breakdown of academic impact, for papers by Qing‐You Kong Breakdown of academic impact, for papers by Bruna Pucci Breakdown of academic impact, for papers by Bao-Wei Wang
Rankless by CCL
2026